Mirae Asset Global Investments’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-29,838
Closed -$2.54M 1608
2020
Q3
$2.54M Sell
29,838
-2,421
-8% -$122K 0.01% 723
2020
Q2
$1.14M Sell
32,259
-28,807
-47% -$842K 0.01% 858
2020
Q1
$823K Buy
+61,066
New +$1.03M 0.01% 882

Mirae Asset Global Investments's IMMU Position: Q4 2020 in Review

Mirae Asset Global Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 29,838 shares — an estimated $2.54M sold.

Mirae Asset Global Investments first reported a position in IMMU in Q1 2020 and held it in 3 quarters. The position peaked at $2.54M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Mirae Asset Global Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 29,838 Immunomedics Inc shares in Q4 2020, an estimated $2.54M.
  • Mirae Asset Global Investments first reported a position in Immunomedics Inc in Q1 2020 and held it in 3 quarters.
  • Mirae Asset Global Investments's Immunomedics Inc position peaked at $2.54M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Mirae Asset Global Investments's 13F filing for Q4 2020, filed 10 Feb 2021.